SCHEMBL565653

SCHEMBL565653

CC(C)CN(Cc1cc(Cl)c2c(c1)OCCCO2)C(=O)[C@@H]1CCCN(Cc2cccc([N+](=O)[O-])c2)C1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.67
KDM4E B2RXH2 8/20 0.44
ALDH1A1 P00352 5/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
POLB P06746 2/20 0.41
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10106776 1.00 PROKR2 (0.67) PROKR2KDM4EALDH1A1KMT2AHTT
SCHEMBL564423 0.96 PROKR2 (0.66) PROKR2KDM4EALDH1A1KMT2AHTT
SCHEMBL565579 0.90 KDM4E (0.54) PROKR2KDM4EALDH1A1KMT2AL3MBTL1
SCHEMBL10107586 0.90 KDM4E (0.54) PROKR2KDM4EALDH1A1KMT2AL3MBTL1
SCHEMBL565568 0.90 PROKR2 (0.73) PROKR2KDM4EALDH1A1KMT2AHTT
SCHEMBL565330 0.90 PROKR2 (0.73) PROKR2KDM4EALDH1A1KMT2AHTT
SCHEMBL565449 0.89 PROKR2 (0.64) PROKR2KDM4EALDH1A1KMT2AHTT
SCHEMBL565506 0.89 PROKR2 (0.66) PROKR2KDM4EALDH1A1KMT2AHTT
SCHEMBL10107192 0.89 PROKR2 (0.64) PROKR2KDM4EALDH1A1KMT2AHTT
SCHEMBL565481 0.89 PROKR2 (0.71) PROKR2KDM4EALDH1A1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885KDM4E 4874/4885ALDH1A1 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.